Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Chengdu Baiyu Pharmaceutical divulges NLRP3 inflammasome inhibitors

June 8, 2021

Taisho Pharmaceutical presents new MMP-2 inhibitors

June 7, 2021

Bayer identifies new PTGER3 antagonists

June 7, 2021

New ROCK1/2 inhibitors identified at Wuhan LL Science and Technology Development Co.

June 7, 2021

Wuhan Optics Valley Yatai Pharmaceutical Research Institute patents HIF-2-alpha inhibitors

June 7, 2021

New anti-EGFRvIII antibodies patented by Regeneron Pharmaceuticals

June 7, 2021

University of California identifies ROR2-targeting antibodies for cancer

June 4, 2021

Hangzhou Hertz Pharmaceutical divulges PD-1/PD-L1 interaction inhibitors

June 4, 2021

Dermira synthesizes new MRGPRX2 antagonists

June 4, 2021

LG Chem discloses new melanocortin MC4 receptor agonists

June 4, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...